Cancer is defined as the uncontrolled growth of the cells that can invade and damage the surrounding cells. Oral cancer or mouth cancer is a type of cancer that effects the oral cavity. A sore of mouth that is not going away, can be an indication of oral cancer. Various types of oral cancers are inclusive of squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others. However, a majority of the reported cases of oral cancer is restricted to the squamous cell carcinoma. Increasing prevalence of oral cancer, rising per capita healthcare expenditures, and growing awareness about oral diseases are some of the major drivers for the market growth during the forecast period. In 2017, according to the Oral Cancer Foundation, 49,750 Americans are estimated to be diagnosed with the oral oropharyngeal cancer. Moreover, it is estimated that 9,750 deaths will be accounted for the same, killing one patient every 24 hours. Additionally, in 2015, according to the Centres for Disease Control and Prevention, in the U.S., the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. However, risks of recurrence of cancer even after the treatment and related side effects followed by high cost of treatment are some of the restraints of the market growth. According to the Dharamshila Hospital, India in 2015, the cost of the treatment of the oral cancers can range from USD 2,995 to USD 14,979.
The global oral cancer treatment market is expected to grow at an approximate CAGR of 7.1% during the forecast period.
Segmentation
The global oral cancer treatment market is segmented on the basis of type, treatment, and end users.
On the basis of type, the market is segmented into squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others.
On the basis of treatment, the market is segmented into surgery, radiotherapy, chemotherapy, and photodynamic therapy (PDT), and others. The surgery segment is sub segmented into tumor resection, glossectomy, laryngectomy, mohs micrographic surgery, and others. The chemotherapy segment is sub segmented into cisplatin, carboplatin, 5-fluorouracil (5-FU), and others.
On the basis of end users, the market is segmented into hospitals & clinics, research organization, academic institutes, and others.
Key players for global oral cancer treatment market
The key players for the global oral cancer treatment market are Bristol-Myers Squibb Company (U.S.) Qilu Pharmaceutical Co., Ltd. (Asia Pacific), Teva Pharmaceutical Industries Ltd. (Isarael), Eli Lilly and Company. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Merck & Co., Inc. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), and others.
Request Customization
Get a Sample
Get a Sample
Request Customization